Laurens Holmes Jr.
Applied Epigenomic Epidemiology Essentials (eBook, ePUB)
A Guide to Study Design and Conduct
47,95 €
47,95 €
inkl. MwSt.
Sofort per Download lieferbar
24 °P sammeln
47,95 €
Als Download kaufen
47,95 €
inkl. MwSt.
Sofort per Download lieferbar
24 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
47,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
24 °P sammeln
Laurens Holmes Jr.
Applied Epigenomic Epidemiology Essentials (eBook, ePUB)
A Guide to Study Design and Conduct
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This applied clinical medicine and public health text introduces the fundamental concepts in epidemiological investigation and demonstrates how to integrate emerging research on epigenomics into practice.
- Geräte: eReader
- ohne Kopierschutz
- eBook Hilfe
- Größe: 5.75MB
This applied clinical medicine and public health text introduces the fundamental concepts in epidemiological investigation and demonstrates how to integrate emerging research on epigenomics into practice.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 350
- Erscheinungstermin: 1. Dezember 2023
- Englisch
- ISBN-13: 9781003816454
- Artikelnr.: 69227187
- Verlag: Taylor & Francis
- Seitenzahl: 350
- Erscheinungstermin: 1. Dezember 2023
- Englisch
- ISBN-13: 9781003816454
- Artikelnr.: 69227187
Laurens Holmes, Jr. is a specialist in Immunology and Infectious Disease as well as an expert in cancer epidemiology and biostatistical modeling. He is a major proponent of aberrant epigenomic modulations in disease incidence, morbidity, prognosis, mortality and survival; and a former Head of the Epidemiology Laboratory at the Nemours Center for Childhood Cancer Research, Wilmington; former clinical and translational science education and training director, Medical College of Wisconsin, Milwaukee; as well as a former Professor of Molecular Epidemiology and Clinical Trials at the University of Delaware, USA. Professor Holmes is currently the Director of the Graduate Public Health Program at Delaware State University, Dover, USA.
Part 1: Epidemiology and Epigenomic Epidemiology Contribution in Clinical
Medicine and Public Health. 1.Introductory Epigenomic Epidemiology: Basic
Concepts and Application. 2.Public Health, Epidemiology and Translational
Epigenomic Epidemiology Perspective. 3.Scientific Research Concept and
Application: Public Health, Clinical Medicine and Epigenomic Epidemiology
Studies. 4.Disease Ascertainment-Diagnostic and Screening Test.
5.Epigenomic Epidemiology: Disease Association, Etiology, Prognosis and
Outcomes. Part 2 Traditional and Modern Epidemiologic Designs 6.Measures of
Disease Occurrence and Effect or Association. 7.Ecologic Design.
8.Cross-Sectional Study Design (Non-experimental). 9.Case-Control
(Comparison/Non-Case) Design. 10.Cohort Designs: Prospective,
Retrospective, Ambi-directional. 11.Human Experimental Design-Clinical
Trials. 12.Epidemiologic Causal Inference: Causality Web, Meta-Analysis,
Quantitative Evidence Synthesis (QES). Part 3 Laboratory Techniques and
Epigenomic Mechanistic Process in Epidemiologic Principles, Concept and
Application. 13.Epigenomic Laboratory Procedures: Mechanistic Process and
Techniques. 14.Epigenomic Studies Perspective: Malignant Neoplasm,
Protastic Adenocarcinoma-Prostate Cancer CaP. 15.Pediatric Acute
Lymphoblastic Leukemia (ALL): Aberrant Epigenomic Modulation Surrogate.
16.Cardiovascular Disease (CVD) : DNA Methylation of Candidate Genes (ACE
II, IFN-¿, AGTR1, CKG, ADD1, SCNN1B and TLR2) in Essential Hypertension.
Medicine and Public Health. 1.Introductory Epigenomic Epidemiology: Basic
Concepts and Application. 2.Public Health, Epidemiology and Translational
Epigenomic Epidemiology Perspective. 3.Scientific Research Concept and
Application: Public Health, Clinical Medicine and Epigenomic Epidemiology
Studies. 4.Disease Ascertainment-Diagnostic and Screening Test.
5.Epigenomic Epidemiology: Disease Association, Etiology, Prognosis and
Outcomes. Part 2 Traditional and Modern Epidemiologic Designs 6.Measures of
Disease Occurrence and Effect or Association. 7.Ecologic Design.
8.Cross-Sectional Study Design (Non-experimental). 9.Case-Control
(Comparison/Non-Case) Design. 10.Cohort Designs: Prospective,
Retrospective, Ambi-directional. 11.Human Experimental Design-Clinical
Trials. 12.Epidemiologic Causal Inference: Causality Web, Meta-Analysis,
Quantitative Evidence Synthesis (QES). Part 3 Laboratory Techniques and
Epigenomic Mechanistic Process in Epidemiologic Principles, Concept and
Application. 13.Epigenomic Laboratory Procedures: Mechanistic Process and
Techniques. 14.Epigenomic Studies Perspective: Malignant Neoplasm,
Protastic Adenocarcinoma-Prostate Cancer CaP. 15.Pediatric Acute
Lymphoblastic Leukemia (ALL): Aberrant Epigenomic Modulation Surrogate.
16.Cardiovascular Disease (CVD) : DNA Methylation of Candidate Genes (ACE
II, IFN-¿, AGTR1, CKG, ADD1, SCNN1B and TLR2) in Essential Hypertension.
Part 1: Epidemiology and Epigenomic Epidemiology Contribution in Clinical
Medicine and Public Health. 1.Introductory Epigenomic Epidemiology: Basic
Concepts and Application. 2.Public Health, Epidemiology and Translational
Epigenomic Epidemiology Perspective. 3.Scientific Research Concept and
Application: Public Health, Clinical Medicine and Epigenomic Epidemiology
Studies. 4.Disease Ascertainment-Diagnostic and Screening Test.
5.Epigenomic Epidemiology: Disease Association, Etiology, Prognosis and
Outcomes. Part 2 Traditional and Modern Epidemiologic Designs 6.Measures of
Disease Occurrence and Effect or Association. 7.Ecologic Design.
8.Cross-Sectional Study Design (Non-experimental). 9.Case-Control
(Comparison/Non-Case) Design. 10.Cohort Designs: Prospective,
Retrospective, Ambi-directional. 11.Human Experimental Design-Clinical
Trials. 12.Epidemiologic Causal Inference: Causality Web, Meta-Analysis,
Quantitative Evidence Synthesis (QES). Part 3 Laboratory Techniques and
Epigenomic Mechanistic Process in Epidemiologic Principles, Concept and
Application. 13.Epigenomic Laboratory Procedures: Mechanistic Process and
Techniques. 14.Epigenomic Studies Perspective: Malignant Neoplasm,
Protastic Adenocarcinoma-Prostate Cancer CaP. 15.Pediatric Acute
Lymphoblastic Leukemia (ALL): Aberrant Epigenomic Modulation Surrogate.
16.Cardiovascular Disease (CVD) : DNA Methylation of Candidate Genes (ACE
II, IFN-¿, AGTR1, CKG, ADD1, SCNN1B and TLR2) in Essential Hypertension.
Medicine and Public Health. 1.Introductory Epigenomic Epidemiology: Basic
Concepts and Application. 2.Public Health, Epidemiology and Translational
Epigenomic Epidemiology Perspective. 3.Scientific Research Concept and
Application: Public Health, Clinical Medicine and Epigenomic Epidemiology
Studies. 4.Disease Ascertainment-Diagnostic and Screening Test.
5.Epigenomic Epidemiology: Disease Association, Etiology, Prognosis and
Outcomes. Part 2 Traditional and Modern Epidemiologic Designs 6.Measures of
Disease Occurrence and Effect or Association. 7.Ecologic Design.
8.Cross-Sectional Study Design (Non-experimental). 9.Case-Control
(Comparison/Non-Case) Design. 10.Cohort Designs: Prospective,
Retrospective, Ambi-directional. 11.Human Experimental Design-Clinical
Trials. 12.Epidemiologic Causal Inference: Causality Web, Meta-Analysis,
Quantitative Evidence Synthesis (QES). Part 3 Laboratory Techniques and
Epigenomic Mechanistic Process in Epidemiologic Principles, Concept and
Application. 13.Epigenomic Laboratory Procedures: Mechanistic Process and
Techniques. 14.Epigenomic Studies Perspective: Malignant Neoplasm,
Protastic Adenocarcinoma-Prostate Cancer CaP. 15.Pediatric Acute
Lymphoblastic Leukemia (ALL): Aberrant Epigenomic Modulation Surrogate.
16.Cardiovascular Disease (CVD) : DNA Methylation of Candidate Genes (ACE
II, IFN-¿, AGTR1, CKG, ADD1, SCNN1B and TLR2) in Essential Hypertension.